| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/2011 | EP2117560B1 A composition for selective serotonin reuptake inhibition and process thereof |
| 01/19/2011 | EP2102222B1 Oligo-beta-(1,3)-glucane-(1,3)-mannose, oligo-beta-(1,3)-glucane-(1,3)-mannitol and derivatives thereof for treating diseases of the immune system, methods for preparing the same and drugs containing them |
| 01/19/2011 | EP2094685B1 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors |
| 01/19/2011 | EP2086540B1 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
| 01/19/2011 | EP2068938B1 Optimization of the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitor imatinib |
| 01/19/2011 | EP2044023B1 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors |
| 01/19/2011 | EP2013209B1 Pyrazolo-tetrahydropyridine derivatives as orexin receptor antagonists |
| 01/19/2011 | EP2013179B1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 01/19/2011 | EP1945634B1 Phenylenebisoxazolidine derivatives and their use as anticoagulants |
| 01/19/2011 | EP1940418B1 Sulfatides for treatment of autoimmune disorders |
| 01/19/2011 | EP1933818B1 Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
| 01/19/2011 | EP1922135B1 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 01/19/2011 | EP1919899B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/19/2011 | EP1906987B1 Methods and compositions for emergency contraception using endothelin receptor antagonists |
| 01/19/2011 | EP1904482B1 Indolylmaleimide derivatives |
| 01/19/2011 | EP1902045B1 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament |
| 01/19/2011 | EP1879862B1 Magnesium salts of hmg-coa reductase inhibitors |
| 01/19/2011 | EP1877553B1 Polymer conjugate enhanced bioassays |
| 01/19/2011 | EP1804791B1 Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 01/19/2011 | EP1799633B1 Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride for use as active ingredient in pharmaceutical compositions |
| 01/19/2011 | EP1765349B1 Opioids for the treatment of the chronic obstructive pulmonary disease (copd) |
| 01/19/2011 | EP1737979B1 Method for diagnosing non-small cell lung cancer |
| 01/19/2011 | EP1720551B1 Alkaloid formulations |
| 01/19/2011 | EP1713489B1 Crystalline form of ibandronate sodium and processes for preparation thereof |
| 01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
| 01/19/2011 | EP1683524B1 Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative |
| 01/19/2011 | EP1670450B1 Pharmaceutical compositions and method of using levodopa and carbidopa |
| 01/19/2011 | EP1656375B1 Novel quinuclidine derivatives and their pharmaceutical use |
| 01/19/2011 | EP1644501B1 Ssx-2 peptides presented by hla class ii molucules |
| 01/19/2011 | EP1644389B1 Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs |
| 01/19/2011 | EP1644336B1 Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 01/19/2011 | EP1610767B1 Morphine controlled release system |
| 01/19/2011 | EP1608623B1 Metal ion chelators and therapeutic use thereof |
| 01/19/2011 | EP1581509B1 1-(amino)indanes as edg receptor agonists |
| 01/19/2011 | EP1547614B1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof |
| 01/19/2011 | EP1542660B1 Sustained released delivery of amphetamine salts |
| 01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2011 | EP1448995B1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 01/19/2011 | EP1433776B1 Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient |
| 01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2011 | EP1365808B1 Compositions for antitumour treatment containing ecteinascidin 743 |
| 01/19/2011 | EP1337234B1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling |
| 01/19/2011 | EP1330442B1 Phthalazinone derivatives |
| 01/19/2011 | EP1325019B1 Antisense modulation of clusterin expression |
| 01/19/2011 | EP1318761B1 System for concurrent tooth repositioning and substance delivery |
| 01/19/2011 | EP1299108B1 A parasiticidal formulation and a method of making this formulation |
| 01/19/2011 | EP1067123B1 Nitrogenous heterocyclic compounds |
| 01/19/2011 | CN201710674U Adsorptive isolating device |
| 01/19/2011 | CN1989117B Substituted benzothiazoles |
| 01/19/2011 | CN1980893B Novel 2,6-diaminopyridine-3-one derivatives |
| 01/19/2011 | CN1977951B Gastrodia elata plant extract for preventing senile dementia and its preparing method |
| 01/19/2011 | CN1976930B 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents |
| 01/19/2011 | CN1950389B Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 01/19/2011 | CN1938010B Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
| 01/19/2011 | CN1929847B Fasudil-containing preparation and method of improving stability thereof |
| 01/19/2011 | CN1816543B Indole derivatives with apoptosis-inducing effect |
| 01/19/2011 | CN1660081B Skin externally used paste |
| 01/19/2011 | CN101952433A PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 01/19/2011 | CN101952297A Solid forms of ortataxel |
| 01/19/2011 | CN101952296A Pyrrolopyrazine kinase inhibitors |
| 01/19/2011 | CN101952295A Pyrrolopyrazine kinase inhibitors |
| 01/19/2011 | CN101952294A Pyrrolopyrazine kinase inhibitors |
| 01/19/2011 | CN101952293A Pyrazolo [1,5-A] pyrimidine compounds |
| 01/19/2011 | CN101952291A 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-B[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases PLK41 to PLK4 for the treatment of proliferative diseases |
| 01/19/2011 | CN101952289A Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections |
| 01/19/2011 | CN101952288A Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 01/19/2011 | CN101952287A Protein kinase inhibitors and use thereof |
| 01/19/2011 | CN101952286A Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 01/19/2011 | CN101952285A Amino triazoles as PI3K inhibitors |
| 01/19/2011 | CN101952284A New tetracyclic compounds |
| 01/19/2011 | CN101952283A Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 01/19/2011 | CN101952282A Thiazole derivatives used as PI 3 kinase inhibitors |
| 01/19/2011 | CN101952281A Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect |
| 01/19/2011 | CN101952280A Bicyclic heterocyclic derivative |
| 01/19/2011 | CN101952279A Azolylmethyloxiranes, use thereof and agents containing the same |
| 01/19/2011 | CN101952278A 3-alkyl-piperazine derivatives and uses thereof |
| 01/19/2011 | CN101952276A 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 01/19/2011 | CN101952275A Modulators for amyloid beta |
| 01/19/2011 | CN101952274A Non-nucleoside reverse transcriptase inhibitors |
| 01/19/2011 | CN101952272A 6-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 01/19/2011 | CN101952267A Cyclopropyl amine derivatives |
| 01/19/2011 | CN101952266A Compound (R) -N*6*-ethyl-6, 7-dihydro-5H-indeno (5, 6- d) thiazole-2, 6-diamine and the use as antipsychotics |
| 01/19/2011 | CN101952264A Isothiazolidine 1,1-dioxide and tetrahydro-2h-1,2-thiazine 1,1-dioxide derivatives as P2X7 modulators |
| 01/19/2011 | CN101952261A Substituted cyclopentanes having prostaglanding activity |
| 01/19/2011 | CN101952260A 4, 5-dihydro-oxazol-2-yl amine derivatives |
| 01/19/2011 | CN101952259A Benzodiazepine compound and pharmaceutical composition |
| 01/19/2011 | CN101952258A Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/19/2011 | CN101952257A Benzimidazole compounds |
| 01/19/2011 | CN101952256A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 |
| 01/19/2011 | CN101952255A Compounds for inhibiting KSP kinesin activity |
| 01/19/2011 | CN101952254A Isoquinoline modulators of ATP-binding cassette transporters |
| 01/19/2011 | CN101952249A Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives |
| 01/19/2011 | CN101952243A 4-dimethylaminobutyric acid derivatives |
| 01/19/2011 | CN101952241A Method of treating vitamin B12 deficiency |
| 01/19/2011 | CN101952240A Process for preparing O-desmethylvenlafaxine |
| 01/19/2011 | CN101952238A Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 01/19/2011 | CN101951937A Method of stimulating the motility of the gastrointestinal system using ipamorelin |
| 01/19/2011 | CN101951930A Oral or enteral composition useful for recovery of physical functions |
| 01/19/2011 | CN101951928A Composition for improving TLR-mediated cellular immunity comprising poly-gamma-glutamic acid |
| 01/19/2011 | CN101951927A Decoy influenza therapies |